IEO – European Institute of Oncology
Founded by Umberto Veronesi, pioneer of breast-conserving surgery and sentinel node biopsy.
Leadership in breast surgery de-escalation, early-phase drug development (Curigliano), and HER2-low/ADC research.
- Breast surgery
- Breast medical oncology
- Early drug development
Breast oncologist and phase 1 leader who co-led DESTINY-Breast06 and shaped the HER2-low concept.
Breast surgeon leading the IEO programme founded by Umberto Veronesi, pioneer of breast conservation.
Molecular oncologist who characterised PML-RARα in acute promyelocytic leukaemia and studies cancer stem cells.
Radiation oncologist who led intraoperative radiotherapy trials and directs research at IEO.
Pages like this
not linked directly; found by shared links- InstitutionFondazione IRCCS Istituto Nazionale dei Tumori
Shares Fondazione AIRC per la ricerca sul cancro, IRCCS Ospedale San Raffaele.
- InstitutionEuropean Society of Surgical Oncology
Shares Paolo Veronesi, Sentinel lymph node biopsy.
- InstitutionInstitut Jules Bordet
Shares Organisation of European Cancer Institutes, HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- ProductPegulicianine
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- PersonSara López-Tarruella
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- IdeaPublic country dashboards for the three WHO breast cancer targets
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- IdeaOne-stop breast clinics: imaging, biopsy and a preliminary answer in a single visit
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC).
- PersonDebu Tripathy
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC).